17.BETA.-(1-KETOETHYL)-.DELTA. SUP(5)-ANDROSTEN-3.BETA.-OL
Traumatic Brain Injury
Christine Marx, MDSmall moleculePhase 2Active
CCC
54/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 73/ 100
Competitive context
92 Active assets in the Traumatic Brain Injury cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MELATONIN Children's National Research Institute | Phase 4 | BBB |
Valproic Acid Northwestern University | Phase 4 | BBB |
PROPRANOLOL Tanta University | Phase 4 | BBB |
N-Acetyl-L-Cysteine HonorHealth Research Institute | Phase 2 | BB |
NEPENTHE Henry M. Jackson Foundation for the Advancement of Military Medicine | Phase 4 | BB |
View all 50 →
Same molecule, other indications
17.BETA.-(1-KETOETHYL)-.DELTA. SUP(5)-ANDROSTEN-3.BETA.-OL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →